Biosimilar Biologics Do Not Always Reduce Out-of-Pocket Cost

Findings seen in large study of commercially insured outpatients examining 7 biologics, before and after biosimilar availability.

Related Keywords

Boston , Massachusetts , United States , Kimberly Feng , Health Forum , Healthday News , Optum Clinformatics Data Mart ,